OUTLOOK Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . OUTLOOK THERAPEUTICS INC
OTLK Stock  USD 0.47  0.05  11.90%   
Analyzing historical trends in various income statement and balance sheet accounts from OUTLOOK THERAPEUTICS's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting OUTLOOK THERAPEUTICS's valuation are summarized below:
Gross Profit
-27.1 M
Market Capitalization
30.9 M
Enterprise Value Revenue
36.6836
Revenue
1.4 M
Earnings Share
(1.86)
There are currently one hundred twenty trending fundamental ratios for OUTLOOK THERAPEUTICS INC that can be evaluated and compared over time across competitors. We recommend to check out OUTLOOK THERAPEUTICS's recent fundamental drivers against the all of the trends between 2010 and 2026. The value of Market Cap is estimated to slide to about 282.7 M. The Enterprise Value is projected to slide to about 275.6 M

OUTLOOK THERAPEUTICS Total Revenue

1.71 Trillion

Check OUTLOOK THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among OUTLOOK THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 100.1 K, Interest Expense of 242.1 K or Selling General Administrative of 48.2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 73.8 K or Days Sales Outstanding of 4.0E-4. OUTLOOK financial statements analysis is a perfect complement when working with OUTLOOK THERAPEUTICS Valuation or Volatility modules.
  
Build AI portfolio with OUTLOOK Stock
Check out the analysis of OUTLOOK THERAPEUTICS Correlation against competitors.

OUTLOOK THERAPEUTICS Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets22.4 T21.4 T3.7 T
Slightly volatile
Short and Long Term Debt Total299.1 B284.9 B48.9 B
Slightly volatile
Other Current Liabilities42.6 T40.6 T7 T
Slightly volatile
Total Current Liabilities55.3 T52.7 T9 T
Slightly volatile
Other Liabilities48.9 K51.4 K5.7 M
Slightly volatile
Property Plant And Equipment Net272.3 B259.3 B44.5 B
Slightly volatile
Accounts Payable12.3 T11.7 T2 T
Slightly volatile
Cash9.8 T9.3 T1.6 T
Slightly volatile
Non Current Assets Total1.4 T1.4 T236.1 B
Slightly volatile
Non Currrent Assets Other1.2 T1.1 T191.5 B
Slightly volatile
Long Term Debt13.1 M12.5 M6.8 M
Slightly volatile
Cash And Short Term Investments9.8 T9.3 T1.6 T
Slightly volatile
Common Stock Total Equity1.9 M2 M10.4 M
Slightly volatile
Common Stock Shares Outstanding30.8 M29.3 M11.3 M
Slightly volatile
Liabilities And Stockholders Equity22.4 T21.4 T3.7 T
Slightly volatile
Non Current Liabilities Total6 T5.7 T979.1 B
Slightly volatile
Other Current Assets7.2 T6.9 T1.5 T
Slightly volatile
Total Liabilities61.3 T58.4 T10 T
Slightly volatile
Property Plant And Equipment Gross192.8 K203 K8.1 M
Slightly volatile
Short and Long Term Debt36.2 M34.4 M16.5 M
Slightly volatile
Preferred Stock Total Equity4 M4.3 M9.7 M
Slightly volatile
Total Current Assets21 T20 T3.4 T
Slightly volatile
Short Term Debt71.1 B67.7 B11.6 B
Slightly volatile
Common Stock650.7 B619.7 B106.4 B
Slightly volatile
Property Plant Equipment60.2 K63.3 K6.3 M
Slightly volatile
Long Term Debt Total6.4 M12.5 M7.5 M
Slightly volatile
Deferred Long Term Liabilities102.1 K107.5 K1.1 M
Slightly volatile
Capital Surpluse278.9 M477.7 M264 M
Slightly volatile
Capital Lease Obligations211.8 K222.9 K1.2 M
Slightly volatile
Non Current Liabilities Other52.5 K55.3 K919.3 K
Slightly volatile
Warrants9.5 M12.3 M8.7 M
Slightly volatile
Capital Stock460.7 K485 K3.5 M
Slightly volatile
Long Term Investments613.1 K497 K812.2 K
Slightly volatile
Short Term Investments11.9 T13.4 T14.7 T
Slightly volatile

OUTLOOK THERAPEUTICS Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization100.1 K105.3 K1.1 M
Slightly volatile
Interest Expense242.1 K254.8 K1.8 M
Pretty Stable
Selling General Administrative48.2 M45.9 M19.8 M
Slightly volatile
Other Operating Expenses82.7 T78.7 T13.5 T
Slightly volatile
Research Development32.8 T31.3 T5.4 T
Slightly volatile
Cost Of Revenue1.6 T1.6 T267.9 B
Slightly volatile
Total Operating Expenses81 T77.2 T13.3 T
Slightly volatile
Minority Interest1.7 M944.4 K1.6 M
Slightly volatile
Interest Income76.7 K80.8 K1.8 M
Slightly volatile
Selling And Marketing Expenses6.6 T6.2 T2 T
Slightly volatile
Preferred Stock And Other Adjustments142 K149.5 K1.2 M
Slightly volatile
Reconciled Depreciation100.1 K105.3 K1.6 M
Slightly volatile
Non Recurring451.1 K474.9 K6.2 M
Slightly volatile

OUTLOOK THERAPEUTICS Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation10.7 T10.2 T1.8 T
Slightly volatile
Begin Period Cash Flow18 T17.2 T2.9 T
Slightly volatile
Dividends Paid181.5 B191.1 B230.3 B
Pretty Stable
Total Cash From Financing Activities54.3 T51.7 T8.9 T
Slightly volatile
End Period Cash Flow9.8 T9.3 T1.6 T
Slightly volatile
Change To Netincome9.1 M11.5 M7.5 M
Slightly volatile
Change Receivables16 K18 K19.6 K
Slightly volatile
Issuance Of Capital Stock34.2 M22.9 M38.5 M
Very volatile
Other Cashflows From Investing Activities720 K810 K884.1 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.00.0235
Slightly volatile
Dividend Yield73.8 K70.3 K45.5 K
Slightly volatile
Days Sales Outstanding4.0E-44.0E-458.4937
Slightly volatile
Average Payables4.8 T4.6 T1.8 T
Slightly volatile
Stock Based Compensation To Revenue5.955.673.5594
Slightly volatile
Inventory Turnover0.330.370.3997
Slightly volatile
Days Of Inventory On Hand719809883
Slightly volatile
Payables Turnover0.150.13311.862
Slightly volatile
Sales General And Administrative To Revenue0.00.01.3451
Slightly volatile
Research And Ddevelopement To Revenue18.1717.3111.2176
Slightly volatile
Cash Per Share219.5 K209.1 K38.9 K
Slightly volatile
Days Payables Outstanding2.3 K2.5 K5.9 K
Slightly volatile
Income Quality0.620.750.7139
Slightly volatile
Current Ratio0.610.340.666
Pretty Stable
Receivables Turnover895.9 K853.2 K660.6 K
Slightly volatile
Average Receivables1.7 M1.9 M2.1 M
Slightly volatile
Revenue Per Share38.4 K36.6 K18.8 K
Slightly volatile
Interest Debt Per Share6.7 K6.4 K1.2 K
Slightly volatile
Debt To Assets0.01460.01530.6151
Slightly volatile
Operating Cycle849809684
Slightly volatile
Days Of Payables Outstanding2.3 K2.5 K5.9 K
Slightly volatile
Ebt Per Ebit1.161.11.0661
Very volatile
Quick Ratio0.260.280.6376
Pretty Stable
Net Income Per E B T1.081.121.0006
Pretty Stable
Cash Ratio0.150.160.4072
Pretty Stable
Days Of Inventory Outstanding719809883
Slightly volatile
Days Of Sales Outstanding4.0E-44.0E-458.4937
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.241.171.1353
Slightly volatile
Fixed Asset Turnover5.925.643.2355
Slightly volatile
Debt Ratio0.01460.01530.6151
Slightly volatile
Price Sales Ratio0.00.0235
Slightly volatile
Asset Turnover0.08310.08750.1785
Slightly volatile

OUTLOOK THERAPEUTICS Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap282.7 M297.5 M2.2 B
Slightly volatile
Enterprise Value275.6 M290.1 M2.2 B
Slightly volatile

OUTLOOK Fundamental Market Drivers

Forward Price Earnings2.8498
Cash And Short Term Investments8.1 T

OUTLOOK Upcoming Events

13th of February 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of December 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About OUTLOOK THERAPEUTICS Financial Statements

OUTLOOK THERAPEUTICS investors utilize fundamental indicators, such as revenue or net income, to predict how OUTLOOK Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-27.8 K-26.4 K
Total Revenue1.6 T1.7 T
Cost Of Revenue1.6 T1.6 T
Stock Based Compensation To Revenue 5.67  5.95 
Research And Ddevelopement To Revenue 17.31  18.17 
Revenue Per Share36.6 K38.4 K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether OUTLOOK THERAPEUTICS INC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if OUTLOOK Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Outlook Therapeutics Inc Stock. Highlighted below are key reports to facilitate an investment decision about Outlook Therapeutics Inc Stock:
How To Invest In OUTLOOK
Details
Is OUTLOOK Stock a good investment?
Details
What is OUTLOOK THERAPEUTICS's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of OUTLOOK THERAPEUTICS Correlation against competitors.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. Anticipated expansion of OUTLOOK directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive OUTLOOK THERAPEUTICS assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(1.86)
Revenue Per Share
0.041
Quarterly Revenue Growth
6.583
Return On Assets
(1.77)
Return On Equity
(0.04)
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between OUTLOOK THERAPEUTICS's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OUTLOOK THERAPEUTICS should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, OUTLOOK THERAPEUTICS's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY